Whether the beneficial effects of CSF‐1R inhibition are due to ameliorating a key process in the development of AD in these mice, or transiently inhibiting the overall effects of microglial inflammatory processes on cognition, has not been established. This evidence concerns the gene CSF1R and Alzheimer disease.